REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioinfra Life Science Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Bioinfra Life Science Inc. Profile Updated: October 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Bioinfra Life Science Inc. is an enterprise based in South Korea. Its main office is in Seoul. The company operates in the Research and Development in Nanotechnology industry. It was incorporated on October 20, 2026. There are currently 3 (2025) people employed by Bioinfra Life Science Inc.. In its most recent financial highlights, the company reported a net sales revenue increase of 572.21% in 2025. During that time, Bioinfra Life Science Inc.’s total assets decreased by 52.44%. The net profit margin of Bioinfra Life Science Inc. increased by 1440.28% in 2025.

Headquarters
7F, Sgi Bldg., 49 Daehak-Ro, Jongno-Gu
Seoul; Seoul;

Contact Details: Purchase the Bioinfra Life Science Inc. report to view the information.

Website: http://bioinfra.co.kr

Basic Information
Total Employees:
Purchase the Bioinfra Life Science Inc. report to view the information.
Financial Auditors:
Purchase the Bioinfra Life Science Inc. report to view the information.
Incorporation Date:
October 20, 2026
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)바이오인프라생명과학
Company Performance
Financial values in the chart are available after Bioinfra Life Science Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
572.21%▲
Total Operating Revenue
728.87%▲
Operating Profit
17.55%▲
EBITDA
49.55%▲
Net Profit/Loss for the Period
16.46%▲
Total Assets
-52.44%▼
Total Equity
-82.27%▼
Operating Profit Margin
943.12%▲
Net Profit Margin
1440.28%▲
Return on Equity (ROE)
-379.38%▼
Debt / Equity
136.3%▲
Quick Ratio
-0.79%▼
Cash Ratio
-0.77%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?